171 related articles for article (PubMed ID: 26337471)
1. The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells.
Cieślar-Pobuda A; Jain MV; Kratz G; Rzeszowska-Wolny J; Ghavami S; Wiechec E
Oncotarget; 2015 Oct; 6(30):29753-70. PubMed ID: 26337471
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
[TBL] [Abstract][Full Text] [Related]
4. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
5. PFKFB3-mediated glycolysis is involved in reactive astrocyte proliferation after oxygen-glucose deprivation/reperfusion and is regulated by Cdh1.
Lv Y; Zhang B; Zhai C; Qiu J; Zhang Y; Yao W; Zhang C
Neurochem Int; 2015 Dec; 91():26-33. PubMed ID: 26498254
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
7. Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells.
Novellasdemunt L; Obach M; Millán-Ariño L; Manzano A; Ventura F; Rosa JL; Jordan A; Navarro-Sabate A; Bartrons R
Biochem J; 2012 Mar; 442(2):345-56. PubMed ID: 22115192
[TBL] [Abstract][Full Text] [Related]
8. PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs.
Chen L; Zhao J; Tang Q; Li H; Zhang C; Yu R; Zhao Y; Huo Y; Wu C
Sci Rep; 2016 Apr; 6():24324. PubMed ID: 27079271
[TBL] [Abstract][Full Text] [Related]
9. Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture.
Hirashima K; Yue F; Kobayashi M; Uchida Y; Nakamura S; Tomotsune D; Matsumoto K; Takizawa-Shirasawa S; Yokoyama T; Kanno H; Sasaki K
Cell Tissue Res; 2019 Mar; 375(3):697-707. PubMed ID: 30284085
[TBL] [Abstract][Full Text] [Related]
10. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells.
Zscharnack K; Kessler R; Bleichert F; Warnke JP; Eschrich K
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):566-78. PubMed ID: 19490427
[TBL] [Abstract][Full Text] [Related]
11. The potential utility of PFKFB3 as a therapeutic target.
Bartrons R; Rodríguez-García A; Simon-Molas H; Castaño E; Manzano A; Navarro-Sabaté À
Expert Opin Ther Targets; 2018 Aug; 22(8):659-674. PubMed ID: 29985086
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
Olmez I; Shen W; McDonald H; Ozpolat B
J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
[TBL] [Abstract][Full Text] [Related]
13. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma.
De Vito C; Riggi N; Cornaz S; Suvà ML; Baumer K; Provero P; Stamenkovic I
Cancer Cell; 2012 Jun; 21(6):807-21. PubMed ID: 22698405
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
Zheng WD; Zhou FL; Lin N
Genet Mol Res; 2015 Dec; 14(4):16872-9. PubMed ID: 26681033
[TBL] [Abstract][Full Text] [Related]
15. The role of PFKFB3 in maintaining colorectal cancer cell proliferation and stemness.
Yan S; Li Q; Li S; Ai Z; Yuan D
Mol Biol Rep; 2022 Oct; 49(10):9877-9891. PubMed ID: 35553342
[TBL] [Abstract][Full Text] [Related]
16. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
[TBL] [Abstract][Full Text] [Related]
17. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
Chesney J
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
[TBL] [Abstract][Full Text] [Related]
18. PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli.
Novellasdemunt L; Bultot L; Manzano A; Ventura F; Rosa JL; Vertommen D; Rider MH; Navarro-Sabate À; Bartrons R
Biochem J; 2013 Jun; 452(3):531-43. PubMed ID: 23548149
[TBL] [Abstract][Full Text] [Related]
19. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
20. PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
Sarkar Bhattacharya S; Thirusangu P; Jin L; Staub J; Shridhar V; Molina JR
Br J Cancer; 2022 Oct; 127(7):1352-1364. PubMed ID: 35794237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
